These findings reveal the importance of the neutrophil‐BAFF‐plasma cell axis in MG pathology and propose new therapeutic strategies targeting neutrophil functional regulation or blocking the BAFF signaling pathway. This evidence concerns the gene TNFSF13B and myasthenia gravis.